Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.2249
-0.0335-12.96%
Post-market: 0.22500.0001+0.04%19:59 EDT
Volume:4.73M
Turnover:1.19M
Market Cap:4.52M
PE:-0.12
High:0.2716
Open:0.2550
Low:0.2211
Close:0.2584
52wk High:4.93
52wk Low:0.2211
Shares:20.12M
Float Shares:18.10M
Volume Ratio:1.24
T/O Rate:26.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8267
EPS(LYR):-2.0700
ROE:-8585.26%
ROA:-56.19%
PB:-0.92
PE(LYR):-0.11

Loading ...

Vivos Therapeutics plans registration statement for transferable shareholder rights offering

Reuters
·
Jun 17

Vivos Therapeutics partners with South Palm Cardiovascular to launch Florida sleep apnea, insomnia services venture

Reuters
·
Jun 16

Vivos Therapeutics Plans to File for Proposed Rights Offering

MT Newswires Live
·
Jun 11

Vivos Therapeutics plans SEC registration filing for proposed transferable rights offering

Reuters
·
Jun 11

Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering

THOMSON REUTERS
·
Jun 11

Vivos Therapeutics enters pact with South Palm Cardiovascular Associates

TIPRANKS
·
Jun 10

Vivos Therapeutics partners with South Palm Cardiovascular to launch Florida sleep apnea, insomnia services venture

Reuters
·
Jun 10

Vivos Therapeutics Announces Key Collaboration Agreement With Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients

THOMSON REUTERS
·
Jun 10

Vivos Therapeutics CEO to present at Small Cap Showcase & WTR Insights

Reuters
·
Jun 09

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

GlobeNewswire
·
Jun 09

Sector Update: Healthcare Stocks Higher Late Afternoon

MT Newswires Live
·
Jun 06

Vivos Therapeutics Agrees Debt for Equity Deal With Streeterville Capital

MT Newswires Live
·
Jun 05

Vivos Therapeutics agrees to exchange up to $4.5 million Streeterville debt into preferred, common stock

Reuters
·
Jun 05

Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of up to $4.5 Million From Streeterville Capital to Support Continued Nasdaq Listing

THOMSON REUTERS
·
Jun 05

Press Release: Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

Dow Jones
·
Jun 05

Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Jun 04

Vivos Therapeutics Earnings Call: Growth Meets Cash Strain

TIPRANKS
·
May 22

Vivos Therapeutics reports Q1 EPS (52c), consensus (45c)

TIPRANKS
·
May 21

Vivos Therapeutics Q1 revenue jumps, driven by SCN acquisition

Reuters
·
May 21

Vivos Therapeutics Q1 EPS $(0.52) Misses $(0.45) Estimate, Sales $5.141M Beat $4.225M Estimate

Benzinga Earnings
·
May 21